Eales disease, first described by Henry Eales in 1880, remains an enigma. The disease,
observed more commonly in the Indian subcontinent than in the rest of the world, occurs in …

Vitreous hemorrhage is associated with a myriad of conditions such as proliferative diabetic
retinopathy, proliferative retinopathy following vascular occlusion and vasculitis, trauma …

Eales' disease, first described by the British ophthalmologist Henry Eales in 1880, is
characterized by three overlapping stages of venous inflammation (vasculitis), occlusion …

Background: Vitreous hemorrhage (VH) is a common vitreoretinal condition causing
impairment of vision due to various etiologies. No consensus exists on the best timing for …

Objective To evaluate the etiologies for dense vitreous hemorrhage in adults with non-
traumatic and reveal management of early vitrectomy for the disease. Methods Study …

Purpose: To investigate the role of intravitreal bevacizumab in Eales disease with dense
vitreous hemorrhage. Methods: This is a prospective randomized control trial. Twenty eyes …

Methods This retrospective case series enrolled 63 patients (71 eyes) who underwent pars
plana vitrectomy (PPV) for the complications of Eales' disease. Indications included …

Purpose To determine visual outcomes and regression of retinal neovascularization
following laser photocoagulation and/or vitrectomy in eyes with Eales' disease. Methods In a …

Purpose: Retinal detachments (RD) secondary to retinal vasculitis are highly complex. We
report the clinical profile and outcome of vitrectomy in RDs secondary to retinal vasculitis in …

Background To report the occurrence of secondary rhegmatogenous retinal detachment
(RRD) after intravitreal bevacizumab injection in patients with Eales' disease. Methods This …